New OpportunitiesMRFF - 2020 Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity
The Medical Research Future Fund (MRFF) - Coronavirus Research Response Initiative: 2020 Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity is open in Sapphire and will close 5:00pm (AEST) on 6 April 2020. No minimum data is due, but interested applicants are requested to contact the NHMRC and Health team as soon as possible if they are intending to apply.
Note that limited time frames are available to complete streamlined applications to facilitate the commencement of research as soon as possible. The NHMRC is also looking for research and industry experts to assess MRFF 2020 Respiratory Medicine Clinical Trials Research on COVID-19 grant opportunity applications – tell us about your expertise on NHMRC's online portal.
Applications to this Medical Research Future Fund (MRFF) Coronavirus Research Response: 2020 Respiratory Medicine Clinical Trials Research on COVID-19 grant opportunity must propose a clinical trial that accelerates the implementation of treatments for severe acute respiratory distress in patients infected with COVID-19 in order to support the response to the COVID-19 outbreak in Australia.
Applicants should note that the research funded by this grant opportunity is not intended to be used for development of vaccines or anti-viral therapies for COVID-19. These issues are the subject of separate MRFF grant opportunities.
The objective of the 2020 Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity is to use clinical trials to accelerate the implementation of treatments for severe acute respiratory distress in patients infected with COVID 19. To be competitive for funding, applicants must propose a clinical trial that delivers against the above objective.
The intended outcome of the research funded under this priority is to use clinical trials to accelerate the implementation of safe and effective treatments for severe acute respiratory distress in patients infected with COVID 19. This includes the identification of plausible pathways to clinical practice within 12 months of commencement.
Applications must address the desired outcomes described in section 1.3 of the grant guidelines. For more information, including the grant guidelines, visit the opportunity on Grants.gov.au.
This opportunity is supported by the Medical Research Future Fund (MRFF).